SCHEMBL1962740

SCHEMBL1962740

COc1ccc(N)c(OCCN(C)C)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
CYP3A4 P08684 1/20 0.56
ROCK2 O75116 1/20 0.53
PTPN1 P18031 1/20 0.48
HTR7 P34969 2/20 0.47
KEAP1 Q14145 1/20 0.46
NFE2L2 Q16236 1/20 0.46
NOS3 P29474 1/20 0.44
NOS1 P29475 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
MEN1 O00255 1/20 0.43
MAPT P10636 1/20 0.43
THRB P10828 1/20 0.43
KMT2A Q03164 1/20 0.43
MTNR1A P48039 1/20 0.43
MTNR1B P49286 1/20 0.43
LTA4H P09960 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
AOC3 Q16853 1/20 0.42
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1962418 0.87 ALDH1A1 (0.56) ALDH1A1CYP3A4ROCK2HTR7KEAP1
Hydrochloric Acid SCHEMBL15994726 0.86 ALDH1A1 (0.59) ALDH1A1CYP3A4ROCK2HTR7KEAP1
SCHEMBL6921826 0.83 ALDH1A1 (0.51) ALDH1A1CYP3A4ROCK2PTPN1MEN1
SCHEMBL1784325 0.83 KDM4E (0.53) ALDH1A1ROCK2KEAP1NFE2L2HRH3
SCHEMBL30129318 0.81 PTPN1 (0.48) ALDH1A1PTPN1HTR7HRH3MTNR1A
SCHEMBL27747991 0.80 ALDH1A1 (0.59) ALDH1A1CYP3A4PTPN1NOS3NOS1
SCHEMBL8263427 0.80 ALDH1A1 (0.59) ALDH1A1CYP3A4NOS3NOS1MEN1
SCHEMBL16372540 0.80 ROCK2 (0.56) ALDH1A1CYP3A4ROCK2HTR7KEAP1
SCHEMBL1962803 0.79 ALDH1A1 (0.54) ALDH1A1CYP3A4HRH3THRBSMN1; SMN2
SCHEMBL5880249 0.79 NOS3 (0.48) ALDH1A1PTPN1HTR7NOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102796075-B Benzocycloheptenes derivative as well as preparation method and medical application thereof INST PHARM & TOXICOLOGY AMMS 2014-03-12 CN disclosed
CN-101481323-B Benzocycloheptenes derivatives, preparation method and medical application thereof POISON MED INST PLA MED ACAD 2013-11-20 CN disclosed
EP-1919892-B1 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME CELGENE CORP (US) 2013-08-14 EP disclosed
EP-1919892-B1 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME CELGENE CORP (US) 2013-08-14 EP disclosed
US-8481568-B2 Isoindole-imide compounds and compositions comprising and methods of using the same CELGENE CORPORATION (US) 2013-07-09 US disclosed
US-8481568-B2 Isoindole-imide compounds and compositions comprising and methods of using the same CELGENE CORPORATION (US) 2013-07-09 US disclosed
US-8481568-B2 Isoindole-imide compounds and compositions comprising and methods of using the same CELGENE CORPORATION (US) 2013-07-09 US disclosed
CN-102796075-A Benzocycloheptenes derivative as well as preparation method and medical application thereof INST PHARM & TOXICOLOGY AMMS 2012-11-28 CN disclosed
US-20110144158-A1 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME SEPRACOR INC. 2011-06-16 US disclosed
US-20110144158-A1 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME SEPRACOR INC. 2011-06-16 US disclosed
WO-2007027527-A2 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME CELGENE CORPORATION (US) 2007-03-08 WO disclosed
US-20070049618-A1 Isoindole-imide compounds and compositions comprising and methods of using the same CELGENE CORPORATION 2007-03-01 US disclosed
US-20070049618-A1 Isoindole-imide compounds and compositions comprising and methods of using the same CELGENE CORPORATION 2007-03-01 US disclosed
US-20070049618-A1 Isoindole-imide compounds and compositions comprising and methods of using the same CELGENE CORPORATION 2007-03-01 US disclosed
EP-0752982-B1 BIPHENYL DERIVATIVES AS 5HT1D ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1998-10-14 EP disclosed
US-5801170-A Heterocyclic biphenylylamides useful as 5HT1D antagonists SMITHKLINE BEECHAM PLC (GB) 1998-09-01 US disclosed
EP-0752982-A1 BIPHENYL DERIVATIVES AS 5HT1D ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1997-01-15 EP disclosed
EP-0733048-A1 HETEROCYCLIC BIPHENYLYLAMIDES USEFUL AS 5HT1D ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-09-25 EP disclosed
WO-1995026328-A1 BIPHENYL DERIVATIVES AS 5HT1D ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1995-10-05 WO disclosed
WO-1995015954-A1 HETEROCYCLIC BIPHENYLYLAMIDES USEFUL AS 5HT1D ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1995-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144158-A1 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME SI, CYP3A5, CYP2D6 ALDH1A1 1081/4885CYP3A4 16/4885ROCK2 1823/4885
US-20070049618-A1 Isoindole-imide compounds and compositions comprising and methods of using the same SI, CYP3A5, CYP2D6 ALDH1A1 1081/4885CYP3A4 16/4885ROCK2 1823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.